Muscle Pharm Corporation (MSLPQ)

[newmex]

Just read an analyst forecast for MSLP going forward in Q3

Arnold Series historic revenue is $46m annual (around $11m a Q)

BioZone historic revenue is $12 annual (around $3m a Q)

Both these revenue streams were terminated in Q2.

When you subtract $14m from the $32m just posted in Q2 and then add potential recapture of customers who switch from Arnold Series to MSLP brand, you see forecasts for Q3 in the low $20s for revenue.

Walmart just terminated for Q3 as well so impact will be even greater.

Granted the Arnold and Biozone terminations were reflected in negative sales in the month of June so Q2 was impacted at some level.

The point is revenue going forward is going to severely impact cash flow to cover losses in a hurry.